A5078804892- Global Cancer Incidence and Screening
- Colorectal Cancer Screening and Detection
- Economic and Financial Impacts of Cancer
- Acute Lymphoblastic Leukemia research
- Cervical Cancer and HPV Research
- Cancer Risks and Factors
- Childhood Cancer Survivors' Quality of Life
- Glioma Diagnosis and Treatment
- Endometrial and Cervical Cancer Treatments
- Pancreatic and Hepatic Oncology Research
- Head and Neck Cancer Studies
- Radiomics and Machine Learning in Medical Imaging
- Brain Metastases and Treatment
- Smoking Behavior and Cessation
- Cancer-related molecular mechanisms research
- Chronic Myeloid Leukemia Treatments
- Neuroblastoma Research and Treatments
- Healthcare Policy and Management
- Cutaneous Melanoma Detection and Management
- Health, Environment, Cognitive Aging
- Chronic Lymphocytic Leukemia Research
- Data Analysis with R
- Health Literacy and Information Accessibility
- BRCA gene mutations in cancer
- Lung Cancer Diagnosis and Treatment
Centers for Disease Control and Prevention
2011-2024
Health Affairs
2024
National Center for Chronic Disease Prevention and Health Promotion
2009-2024
Centers for Disease Control and Prevention
2021
Institut National du Cancer
2021
Cancer Institute (WIA)
2021
Cancer Research Foundation
2021
London School of Hygiene & Tropical Medicine
2021
Centre International De Reference Chantal Biya
2021
Swiss Cancer League
2021
The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), National Institute (NCI), North Association of Central Registries (NAACCR) collaborate to provide annual updates on cancer occurrence trends in United States. This Annual Report highlights survival rates. Data were from CDC- NCI-funded population-based registry programs compiled by NAACCR. Trends age-standardized incidence death rates all cancers combined leading types sex estimated joinpoint analysis...
Survival from metastatic cutaneous melanoma is substantially lower than for localized disease. Treatments have been limited, but remarkable clinical improvements reported in trials the last decade. We described characteristics of US patients diagnosed with during 2001-2013 and assessed trends short-term survival distant-stage disease.Trends 1-year net were estimated using Pohar Perme estimator, controlling background mortality life tables all-cause rates by county residence, single year age,...
Breast cancer is commonly diagnosed among women, accounting for approximately 30% of all cases reported women.* A slight annual increase in breast incidence occurred the United States during 2013-2017 (1). To examine trends women aged ≥20 years by race/ethnicity and age, CDC analyzed data from U.S. Cancer Statistics (USCS) 1999-2018. Overall, rates decreased an average 0.3% per year, decreasing 2.1% year 1999-2004 increasing 2004-2018. Incidence increased non-Hispanic Asian or Pacific...
Abstract Background Cancer is a leading cause of death by disease among children and adolescents in the United States. This study updates cancer incidence rates trends using most recent comprehensive US registry data available. Methods We used from Statistics to evaluate counts, age-adjusted rates, younger than 20 years age diagnosed with malignant tumors between 2003 2019. calculated average annual percent change (APC) APC joinpoint regression. Rates were stratified demographic geographic...
Abstract Background Standardization of procedures for data abstraction by cancer registries is fundamental surveillance, clinical and policy decision-making, hospital benchmarking, research efforts. The objective the current study was to evaluate adherence four components (completeness, comparability, timeliness, validity) defined Bray Parkin that determine registries’ ability carry out these activities hospital-based National Cancer Database (NCDB). Methods Tbis used from U.S. Statistics,...
Cancers of the oral cavity and pharynx account for 3% cancers diagnosed in United States* each year.Cancers at these sites can differ anatomically histologically might have different causal factors, such as tobacco use, alcohol infection with human papillomavirus (HPV) (1).Incidence combined pharyngeal declined during 1980s but began to increase around 1999 (2,3).Because use has States, accompanied by a decrease incidence many tobaccorelated cancers, researchers suggested that be attributed...
Background Although pediatric cancer mortality and survival have improved in the United States over past 40 years, differences exist by age, race/ethnicity, site, economic status. To assess progress, this study examined recent data for individuals younger than 20 years. Methods Age‐adjusted death rates were calculated with National Vital Statistics System 2002‐2016. Annual percent changes (APCs) average annual (AAPCs) joinpoint regression. Five‐year relative was on basis of Program Cancer...
Abstract BACKGROUND. Researchers have not been able to examine cancer incidence rates in Appalachia because high‐quality data uniformly available across the region. This study is first report for a large proportion of Appalachian population and describe differences between Northern, Central, Southern Appalachia. METHODS. Forty‐four states District Columbia provided information diagnosis years 2001 through 2003 from registries that met criteria. Eleven 13 with counties Appalachia, covering...
Approximately 15,000 persons aged <20 years receive a cancer diagnosis each year in the United States (1). National surveillance data could provide understanding of geographic variation occurrence new cases to guide public health planning and investigation (2,3). Past research on pediatric incidence described differences by U.S. Census region but did not state-level estimates (4). To adequately describe among States, CDC analyzed from Cancer Statistics (USCS) during 2003-2014 identified...
Limited literature is available about cancer in the Appalachian Region. This only known analysis of all cancers for Appalachia and non-Appalachia covering 100% US population. incidence trends were evaluated by state, sex, race compared with those found non-Appalachian regions.US counties identified as or non-Appalachian. Age-adjusted rates, standard errors, confidence intervals calculated using most recent data from United States Cancer Statistics 2004 to 2011.Generally, carries a higher...
Background: Risk factors for endometrial cancer, such as hormone replacement therapy (HRT) and obesity, have changed significantly in the last decade. We investigated trends cancer histologic subtypes on a national level during 1999–2006. Methods: Data covering 88% of U.S. population were from central registries National Program Cancer Registries (NPCR) Surveillance, Epidemiology, End Results (SEER) programs that met high-quality United States Statistics (USCS) criteria. Our analyses...
Human papillomavirus (HPV) vaccines can potentially prevent greater than 90% of cervical and anal cancers as well a substantial proportion vulvar, vaginal, penile, oropharyngeal caused by certain HPV types. Because more 38,000 HPV-associated are diagnosed annually in the United States, current studies needed to understand how relative survival varies for each these demographic characteristics, such race age.The authors examined high-quality data from 27 population-based cancer registries...
Many factors contribute to changes in cancer incidence, including risk exposures or the use of screening tests (1). To monitor incidence and assess progress toward achieving Healthy People 2020 objectives, CDC analyzed data from U.S. Cancer Statistics (USCS) for 2012, most recent available. USCS includes high quality CDC's National Program Registries (NPCR) Institute's Surveillance, Epidemiology, End Results (SEER) program, survival NPCR, mortality Vital System (2). In a total 1,529,078...
Abstract Background Breast cancer remains a leading cause of morbidity and mortality among women in the United States. Previous analyses show that breast incidence increased from 1999 to 2018. The purpose this article is examine trends mortality. Methods Analysis 2020 data Centers for Disease Control Prevention, National Center Health Statistics, by race/ethnicity, age, US Census region. Results It was found overall decreasing but varies age group, largest decrease observed non‐Hispanic...
Abstract Background The majority of reported cancer survival statistics in the United States are generated using National Cancer Institute’s publicly available Surveillance, Epidemiology, and End Results (SEER) data, which prior to 2019 represented 28% US population (now 37%). In case rare cancers or special subpopulations, data sets based on a larger portion may contribute new insights into these low-incidence cancers. purpose this study is characterize histology-specific patterns for all...
Abstract Plasma cell myeloma (also called multiple myeloma), solitary plasmacytoma, and extramedullary plasmacytoma are primarily diseases of the elderly. Evidence suggests an association between excess body weight myeloma. Few population‐based studies have examined incidence mortality each site in one study. We analyzed death rates by (solitary myeloma) gender, age, race/ethnicity, rural‐urban status among adult males females (aged 20 years or older) United States during 2003‐2016. Trends...
Abstract Background: Few population-based studies have examined incidence and mortality of cancers the biliary tract, including intrahepatic bile duct, extrahepatic ampulla Vater, overlapping or other lesions tract in one study. Methods: To further understanding recent rates cancers, we used data, to examine during 2013 2017. We how varied by sex, age, race/ethnicity, U.S. census region, stage at diagnosis. Results: Intrahepatic duct was most common cancer, with an rate 1.49 per 100,000...
We describe rates and trends in kidney cancer incidence mortality identify disparities between American Indian/Alaska Native (AI/AN) White populations.To improve identification of AI/AN race, data were linked with Indian Health Service (IHS) patient records. Analysis focused on residents IHS Contract Delivery Area counties; Hispanics excluded. calculated age-adjusted (2001-2009) death (1990-2009) by sex, age, region.AI/AN persons have a 1.6 times higher 1.9 rate than Whites. Despite...
Although cancer represents many heterogeneous diseases, some types share common risk factors. For example, conclusive evidence links at multiple sites with tobacco use, alcohol human papillomavirus (HPV) infection, excess body weight, and physical inactivity (1,2). To monitor changes in incidence assess progress toward achieving Healthy People 2020 objectives,* CDC analyzed data from the U.S. Cancer Statistics (USCS) set for 2013, most recent year which survival are available. In a total of...
Breast cancer among males in the United States is rare; approximately 2,300 new cases and 500 associated deaths were reported 2017, accounting for 1% of all breast cancers.* Risk male increases with increasing age (1), compared women, men receive diagnoses later life often at a stage disease (1). Gradual improvement survival from 1976-1985 to 1996-2005 has been more evident women than Studies examining differences female patients observed that non-Hispanic White (White) females had higher...
Background Disparities in cancer incidence have not been described for urban American Indian/Alaska Native (AI/AN) populations. The purpose of the present study was to examine rates (2008‐2017) and trends (1999‐2017) leading cancers non‐Hispanic AI/AN (NH AI/AN) compared White (NHW) populations living same areas. Methods Incident cases from population‐based registries were linked with Indian Health Service patient registration database improved racial classification NH This limited counties...
Cancer has many causes, some of which can, at least in part, be avoided through interventions known to reduce cancer risk. Healthy People 2020 objectives call for reducing colorectal incidence 38.6 per 100,000 persons, late-stage breast 41.0 women, and cervical 7.1 women. To assess progress toward reaching these targets, CDC analyzed data from U.S. Statistics (USCS) 2010. USCS includes CDC's National Program Registries the Institute's Surveillance, Epidemiology, End Results (SEER) program...